Salicylate gel restrictions

The Medicines and Healthcare products Regulatory Agency (MHRA) has advised that topical oral pain relief gels containing salicylate salts should be contraindicated in children under 16 years.

The restrictions are a precautionary measure only to remove the theoretical risk of Reye’s syndrome in children.

The new advice from new advice for topical oral salicylate products brings them in line with other oral salicylate containing products.

The products affected by this advice include Bonjela, Bonjela Cool Mint and Pyralvex. The advice does not affect Bonjela Teething Gel, as it does not contain salicylates.

Further information: MHRA letter to healthcare professionals

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more